The U.S. Food and Drug Administration has approved Johnson & Johnson’s drug Invokana, which will be used to treat type 2 diabetes.
According to the New York Times, Invokana is the first of a new class of diabetes medication. It causes blood sugar to be excreted in the urine, as opposed to many other drugs on the market that work by affecting the supply or use of insulin.
Last year, the FDA ...
continue reading...